We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Targets – News and Features

News

Clinical Failures Could be Reduced Through the use of Human Tissue

Asterand recognises the benefits of utilizing human tissue during the drug discovery and development process.
News

Research and Markets Adds Nanotechnology for Drug Discovery and Drug Design to Their offering

Nanotechnology drug-delivery companies seeking to partner with pharmaceutical companies face competition from a plethora of available drug-delivery systems.
News

Take a Look at Some Recent Case Studies of Protein-Protein Interaction Drug Discovery

Research and Markets adds the Decision Resources report "Protein-Protein Interactions: Are They Now Druggable Targets?" to their offering.
News

BioTrove and Blue Sky Introduce Screening Solution Portfolio

Blue Sky will provide pharma-grade proteins that pharmaceutical companies can quickly screen against their entire small molecule libraries.
News

BSI Licences Northeastern University Technology for Biomarker Discovery

The licensed technology offers a major opportunity to discover and validate trace level disease specific biomarkers.
News

CytRx Provides 2006 Update on RNAi-Based Drug Discovery Programs

Progress made toward developing next generation molecular medicines to treat obesity and type 2 diabetes.
News

FEI and Sidec Tackle Validation of Drug Targets

The two companies will collaborate on the commercialization of Protein Tomography solutions.
News

CytRx Announces Publication of Article Discussing Use of RNAi Screening Platform

The Article validates Company's RNAi approach to discovering targets for developing molecular medicines to treat obesity and type 2 diabetes.
News

Broad Partnerships to Enable Maximisation of Opportunities in the Expression Proteomics Sector

Proteomics is divided into protein separation and identification methods, based on its application segments.
News

Varian Acquires Fourier Transform Mass Spectrometry Technology

The acquisition will increase the company's participation in the study of proteins, nucleic acids and drug metabolites.
Advertisement